{"filing":{"accession_number":"0001193125-26-337953","cik":"0001484612","ticker":"OM","company_name":"Outset Medical, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"om-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/om-20260806.htm"},"events":[{"id":25599,"run_id":23235,"accession_number":"0001193125-26-337953","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states that Outset Medical issued a press release announcing financial results for the quarter, with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, revenue metrics ($31.6M, up 1% YoY), gross margin expansion to 42%, net loss of $18.0M, and full-year 2026 guidance of $125-130M revenue. This is a standard quarterly earnings announcement material to investors.","company_name":"Outset Medical, Inc.","ticker":"OM","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26478,"accession_number":"0001193125-26-337953","item_number":"2.02","item_title":"Result of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states that Outset Medical issued a press release announcing financial results for the quarter, with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, revenue metrics ($31.6M, up 1% YoY), gross margin expansion to 42%, net loss of $18.0M, and full-year 2026 guidance of $125-130M revenue. This is a standard quarterly earnings announcement material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:16:06.643994+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26478,"accession_number":"0001193125-26-337953","item_number":"2.02","item_title":"Result of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states that Outset Medical issued a press release announcing financial results for the quarter, with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, revenue metrics ($31.6M, up 1% YoY), gross margin expansion to 42%, net loss of $18.0M, and full-year 2026 guidance of $125-130M revenue. This is a standard quarterly earnings announcement material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:16:06.643994+00:00","company_name":"Outset Medical, Inc.","ticker":"OM","filing_date":"2026-08-06"}]}